VMViktor A. Makarin

Viktor A. Makarin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Viktor A. Makarin has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ethanol Sclerotherapy Combined with Radiofrequency Ablation in the Treatment of Toxic Adenoma: Clinical Case

    by G. T. Gumerova, В. А. Макарьин, A. F. Tushova, A. F. Fazlyeva, A. I. Ishbulatova, S. P. Klimets, E. A. Nadezhdina, A. D. Neryakhin

    Introduction. Thyrotoxic states are the result of an overproduction of thyroid hormones. Statistics from Russia indicate an increasing incidence of thyrotoxicosis, with 132 cases documented per 100,000 population in 2018. Diffuse toxic goiter is among the most frequent pathologies associated with thyrotoxic conditions. Hyperthyroidism can also result from toxic thyroid adenomas. Toxic nodular goiter is a condition that can manifest in various ways, including single lobe involvement with a solitary nodule or multiple nodules within one or both lobes. The clinical features of these adenomas encompass local symptoms, including cosmetic concerns, and systemic thyrotoxicosis, which inform subsequent management strategies. Aim. The development of personalized, minimally invasive approaches for treating thyroid neoplasms is driven by the need to preserve functioning organ tissue. Materials and methods. This article details a clinical case involving a patient diagnosed with nodular goiter exhibiting signs of thyrotoxicosis. We developed a combined surgical intervention, involving staged ethanol sclerotherapy followed by radiofrequency ablation of the nodule. Results and discussion. The minimally invasive thyroid intervention resulted in the normalization of hormonal balance, a 7-fold reduction in nodule size, an improvement in quality of life, and the restoration of natural neck contours. Conclusion. The study highlights the potential of interventional endocrine surgery as a means of preserving organ function in patients with toxic nodular formations.

  • Open Access

    Treatment of nodular goiter with compression of the neck organs in a step-by-step manner: sclerotherapy, radiofrequency ablation

    by G. T. Gumerova, A. F. Fazlieva, S. P. Klimets, N. S. Suleymanova, A. I. Ishbulatova, I. V. Asfandiyarova, A. D. Neryakhin, V. A. Makariin, A. A. Uspenskaya

    As a rule, patients with a multi-nodular goiter are not regularly observed by doctors, the reason for seeking medical help is the presence of a growing formation on the neck or the development of compression syndrome. More often, such patients are referred for surgical treatment, namely for hemi- or total thyroidectomy. This study presents a clinical case of non-surgical treatment in stages using ethanol sclerase therapy and radiofrequency ablation (RFA), which allowed the organ to be preserved, while achieving the necessary cosmetic effect, there is no damage to surrounding tissues and organs. The combined treatment of diffuse nodular goiter made it possible to reduce the size of the neoplasm by 21 times from the initial one during the treatment period from 2019 to 2021, eliminated the cosmetic defect and compression syndrome. Sclerotherapy and RFA can act as an alternative to surgical methods, but without scarring of the neck. Interventional methods are effective in the treatment of thyroid nodules, including large ones.

  • Open Access

    ФАКТОРЫ РИСКА ПОВТОРНЫХ ОПЕРАЦИЙ ПО ПОВОДУ ПЕРВИЧНОГО ГИПЕРПАРАТИРЕОЗА В СРЕДНИЕ СРОКИ НАБЛЮДЕНИЯ

    by Д. М. Бузанаков, И. В. Слепцов, Р. А. Черников, А. А. Семенов, К. Ю. Новокшонов, Ю. В. Карелина, В. А. Макарьин, А. А. Успенская, Н. И. Тимофеева, Н. А. Горская, et al.

  • Persistence of primary hyperparathyroidism: a single-center experience

    by Dmitrii M. Buzanakov, Ilya V. Sleptsov, Arseny A. Semenov, Roman A. Chernikov, Konstantin Y. Novokshonov, Yulia V. Karelina, Natalya I. Timofeeva, Anna A. Uspenskaya, Viktor A. Makarin, Igor K. Chinchuk, et al.

    Background Parathyroidectomy is the only definitive treatment for primary hyperparathyroidism (PHPT). Precise localization of abnormal glands is a key to a successful surgery. Most patients are expected to be successfully treated with focused parathyroidectomy. However, this approach is associated with a risk of existing multiglandular disease which may lead to the postoperative persistence of PHPT. Methods Eight hundred ten patients who underwent an initial surgery for PHPT at SPBU Hospital in 2017–2018 were included in the study. Preoperative imaging results were evaluated. Multivariate logistic regressions were calculated to estimate predictive values of preoperative data for the risk of postoperative persistence and risk of MGD. Results Multiglandular disease was found to be a leading cause of persistent hyperparathyroidism. An anamnesis of thyroid surgery was found to be a significant risk factor for the persistence of hyperparathyroidism. The rate of persistence did not differ significantly between groups with bilateral neck exploration and focused parathyroidectomy. Age, sex, body mass index as well as negative results of preoperative US, MIBI, and 4D CT were not independently associated with a higher risk of MGD. All preoperative imaging modalities showed from low to moderate sensitivity for the detection of MGD. The frequency of cases of a missed second adenoma did not differ significantly between patients with concordant and discordant preoperative data. There were 7 cases with previously unsuspected second adenomas found solely due to bilateral neck exploration. Conclusions None of the combination of preoperative visualization modalities was able to rule out the MGD and reliably identify patients for focused parathyroidectomy. Additional preoperative visualization failed to improve overall results. Bilateral neck exploration appeared to have a slight benefit for the patients with concordant preoperative imaging results.


  • Lidocaine in thyroid and parathyroid surgery with intraoperative emg-monitoring — to use or to forbid?

    by A.YU. Kulikov, V.A. Makarin, O.V. Kuleshov, M.A. Alekseev, S.M. Efremov, R.A. Chernikov, Yu.N. Fedotov

    Электромиографический нейромониторинг (ЭМГ-НМ) все шире используется при выполнении оперативных вмешательств на щитовидной и околощитовидных железах. Сохранность ларинготрахеальных рефлексов при отсутствии нейромышечного блока представляет клиническую проблему. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить влияние лидокаина, введенного в зону контакта манжетки эндотрахеальной трубки со слизистой оболочкой гортани, на электромиографический нейромониторинг и ларинготрахеальные рефлексы во время оперативных вмешательств на щитовидной и околощитовидных железах. МАТЕРИАЛ И МЕТОДЫ Проведено проспективное исследование, в которое включены 56 пациентов, подвергшихся плановым оперативным вмешательствам на щитовидной и околощитовидных железах с использованием ЭМГ-НМ в условиях общей комбинированной анестезии. Пациенты разделены случайным образом на две группы, в одной из которых использовали антирефлексивные эндотрахеальные трубки и в зону контакта манжетки со слизистой оболочкой гортани вводили лидокаин. Оценивали возможность проведения ЭМГ-НМ, потребность в наркотических анальгетиках и клинические проявления ларинготрахеальных рефлексов. РЕЗУЛЬТАТЫ Введение лидокаина на указанном уровне статистически значимо не влияло на показатели миографии возвратного гортанного нерва (1,81±0,82 мВ по сравнению с 2,05±0,63 мВ у пациентов контрольной группы, p=0,25). Различия в эпизодах проявлений ларинготрахеальных рефлексов (2 по сравнению с 5 в контрольной группе, p=0,42) и общей потребности в фентаниле оказались статистически незначимыми. ЗАКЛЮЧЕНИЕ Окончательное значение применения лидокаина в хирургии щитовидной и околощитовидных желез с электромиографическим нейромониторингом будет определено в процессе дальнейшего изучения.


  • Open Access

    Peculiarity of recovery of the hypothalamic-pituitary-gonadal (hpg) axis, in men after using androgenic anabolic steroids

    by Mykola P. Lykhonosov, Alina Y. Babenko, Viktor A. Makarin, Yury N. Fedotov

    BACKGROUND: Spontaneous recovery of the hypothalamicpituitarygonadal (HPG) axis after cessation of testosterone replacement therapy or after male contraception may take up to 24 months. There is insufficient data on the duration of recovery of HPG axis after abuse of androgenic anabolic steroids (AAS). AAS users use post-cycle therapy (PCT) to restore HPG axis, the effectiveness of which is unknown and needs further investigation. AIMS: To evaluate the recovery of HPG axis in men, AAS users, after a 3-month of cessation of their use and after PCT. METHODS: An observational, single-center, prospective, sampling, open, uncontrolled study was conducted among male AAS users. While using of AAS and 3 months after the refusal of their administration and PCT, the clinical symptoms of hypogonadism were evaluated, luteinizing hormone (LH), follicle-stimulating hormone (FSH), total testosterone (Tt), prolactin, estradiol, inhibin B, thyroid-stimulating hormone (TSH) were determined. The scheme of rehabilitation therapy was the same and did not change throughout the study. Recovery criteria: Tt 3.4 ng/ml and LH 1.24 mIU/ml. The study was conducted from January to August 2019. Fishers exact test, Mann-Whitney U-test, and Spearmans rank correlation coefficient were used. The differences were considered statistically significant at p0.05. RESULTS: The study included 44 men, their age 29 years [27.75; 34], the duration of the use of AAS is 6 months [3.52; 7]. During the use of AAS: LH 0.2 mIU/ml [0.04; 0.47], Tt 4.34 ng/ml [1.05; 8.81]. In this group, the number of men with a LH level 1.24 mIU / ml was 84% (n=37) and Tt 3.4 ng/ml was 47.7% (n=21). After 3 months, the LH level reached 4.12 mIU/ml [2.58; 5.84], Tt 4.55 ng/ml [3.76; 6.24]. At the same time, the level of Tt 3.4 ng/ml remained in 20.5% (n=9), and LH 1.24 mIU/ml in 4.5% (n=2) men. According to the level of recovery of LH and Tt, patients were divided into two groups: with satisfying (n=35; 79.5%) and poor (n=9; 20.5%) recovery. A clear correlation was established between the duration of use (-0.857; p0.0001), the amount (-0.443; p=0.003), the dose (-0.7825; p0.0001), the type of AAS (-0.698; p0.0001) and testosterone level recovery. A correlation between inhibin B and Tt (0.418; p=0.005) was revealed. CONCLUSIONS: A three-month refusal to use AAS with PCT led to the restoration of HPG axis a in 79.5% of the volunteers. In 20.5% of cases, recovery did not occur. The negative effect of the duration of use, the number of simultaneously administered drugs, their dose and type of AAS on the restoration of HPG axis was established. The level of inhibin B may serve as a marker for the restoration of spermatogenic epithelium.


  • Open Access

    The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity

    by Mykola P. Lykhonosov, Alina Yu. Babenko, Viktor A. Makarin, Yury N. Fedotov

    BACKGROUND: The widespread use of AAS for non-medical purposes is more than often becoming the cause of secondary hypogonadism. The study of the formation of the negative attitude towards the use of AAS among the gym visitors is quite relevant. AIMS: To identify the frequency of the formation of a motivated refusal to continue taking androgenic anabolic steroids among men who voluntarily declared their use. MATERIALS AND METHODS: The study included 44 men, all users of AAS. There has been estimated the effectiveness of the clinical examination: how ready they were to disclose information about the use of AAS (drugs, doses, regimens, duration) or how much they were aware of the mechanisms of action of AAS and their effects on the body. The participants were also asked to evaluate their psychological and emotional state (on the scale Index of life satisfaction, Hamiltons depression, aggressiveness). The experience of our informational lectures on the topic Risks of using AAS prior to the selection of volunteers for research, anonymous surveys and interviews with potential participants in the clinical trial, the clinical work itself with the selected volunteers, the characteristic features of a medical history and tests that we identified were compared with clinical recommendations for hypogonadism diagnostic (domestic and foreign). RESULTS: More than 105 gym visitors responded positively to a motivated offer (free medical consultation and laboratory tests) to participate in a clinical study. Based on the results of the individual interview, 54 men (51.4%) who indicated the use of AAS signed an informed consent. 44 volunteers (41.9%) completed all stages of the study. Among them, 32 participants (72.7%) were aware of the mechanisms of action and side effects of AAS. 21 volunteers (47.7%) filled in the scales. The index of life satisfaction was determined as high, equal to 34 [29; 38] points; the index of aggressiveness was higher than the generally accepted standard and composed 27 [25; 29] points, the level of depression corresponded to a mild depressive disorder, equal to 9 [3; 12] points. Over the use of AAS 22.7% (n = 10) of the examined noted an increase in aggressiveness, which they themselves associated with the use of steroids. The clinical symptoms of hypogonadism (decreased libido, erectile dysfunction) after the cancellation of AAS were indicated by 25% (n = 11) of the volunteers and that was one of the reasons they continued to use anabolics. 31.8% (n = 14) of the participants were ready to completely stop using the steroids. CONCLUSIONS: Individual informational interviews aimed at providing knowledge about the negative effects of steroids on the body motivated the desire to stop using them amongst 31.8% of AAS users. The obtained data points out to a developed AAS addiction which requires the involvement of psychiatrists to get rid of it.


  • Open Access

    INTRAOPERATIVE CONTINUOUS NEUROMONITORING OF LARYNGEAL RECCURENT NERVES IN PATIENTS WITH THYROID CANCER

    by Виктор Макарьин, Anna Uspenskaya, Arseniy Semenov, Natalya Timofeeva, Roman Chernikov, Ilya Sleptsov, Igor Chinchuk, Yuliya Karelina, Konstantin Novokshonov, Yelisey Fedorov, et al.

    Laryngeal muscles paresis ranks second in prevalence of postoperative complications after thyroid surgery. Intraoperative neuromonitoring (IONM) of recurrent laryngeal nerve (RLN) results in reduction of cases with dysphonia and prevents such severe complication as bilateral paresis. Currently there are two types of monitoring: intermittent and continual. When using intermittent IONM surgeon has no opportunity to control electrophysiology state of RLN during intervals between stimulations. In case of continual IONM date on amplitude and latency are available to surgeon in real time every second, allowing him instantly react to any disturbance of neural transmission to prevent its damage by changing surgical manipulation. This work presents the first experience of using continual neuromonitoring of RLN in Russia, the procedure is described in details its safety. It is represented the possibility of prevention of bilateral laryngeal muscles paresis. Парез мышц гортани является вторым после гипопаратиреоза по распространенности осложнением при хирургических вмешательствах на щитовидной железе. Использование интраоперационного нейромониторинга помогает сократить количество нарушений голоса и предотвратить такое грозное осложнение, как двусторонний парез мышц гортани. В настоящее время существует два вида мониторинга: переменный и постоянный. При переменном нейромониторинге у оператора нет возможности контролировать электрофи-зиологическое состояние гортанных нервов в промежутке между стимуляциями. При постоянном мониторинге данные по амплитуде и латентности доступны хирургу в реальном времени ежесекундно, что позволяет моментально отреагировать на нарушения проведения нервного импульса по нерву и предотвратить его повреждение, изменив хирургическую тактику. В работе представлен первый опыт выполнения постоянного мониторинга в России, подробно описана методика, показана безопасность, продемонстрирована возможность профилактики двустороннего пареза мышц гортани у пациентов с раком щитовидной железы. Цель: оценить результаты использования постоянного мониторинга гортанных нервов при хирургических вмешательствах на щитовидной железе и влияние его на сердечно-сосудистую систему пациента в процессе выполнения оперативного вмешательства. Материалы и методы: с октября 2016 по август 2017 гг. на базе отделения эндокринной хирургии Клиники высоких медицинских технологий им. Н. И. Пирогова Санкт-Петербургского университета (Северо-Западный центр эндокринологии и эндокринной хирургии) 118 пациентам были выполнены оперативные вмешательства на щитовидной железе с установкой дельта-электрода на n. vagus с постоянной стимуляцией последнего. Группа пациентов включала: 101 пациента с диагнозом «папиллярная карцинома», 12 пациентов с диагнозом «медуллярная карцинома», 5 пациентов с диагнозом «анапластическая карцинома». Для проведения нейромониторинга использовали нейромонитор С2 (Inomed, Emmendingen, Germany). Всем пациентам перед операцией и в послеоперационном периоде выполняли ларингоскопию и регистрировали изменения функции голосовых складок. В работе проведен анализ взаимосвязи изменения амплитуды и латентности при проведении нейромониторинга и развития послеоперационного пареза мышц гортани, определены средние значения по амплитуде и латентности для блуждающего нерва слева и справа. Результаты. В исследуемой группе было следующее распределение пациентов по полу: 94 женщины и 24 мужчины. Средний возраст женщин и мужчин составил 46,1 ± 18 и 44,2 ± 15 лет соответственно. Получено достоверно значимое снижение уровня амплитуды в V2 в сравнении с V1 (p=0,0454), при этом в R2 значимых изменений в сравнении с R1 не получено (p=0,8927). В отведениях V2 в сравнении с V1...